Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$2.12M
40K shares
What this filing means
KAKKIS EMIL D plans to sell 40K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $2.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2024ACC: 0002002698-24-000359
DirectorOfficer· President & CEO
Since Mar 2026
40K
Shares to sell
$2.12M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
FOUNDERS SHARES
CASH
4/27/2010
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/27/2010 | FOUNDERS SHARES CASH | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20K
Market value
$1.00M
8/6/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$1.12M
9/3/2024
Total
Units
40K
Value
$2.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/6/2024 | 20K | $1.00M | — | Completed |
| Planned — Approximate Date | ||||
9/3/2024 | 20K | $1.12M | NASDAQ | Planned |
| Total | 40K | $2.12M | ||